Quinoxaline
Names
[ CAS No. ]:
91-19-0
[ Name ]:
Quinoxaline
[Synonym ]:
Quinoxaline
1,4-Benzodiazine
EINECS 202-047-4
Benzopyrazine
1,4-Diazanaphthalene
MFCD00006719
Phenopiazine
Phenpiazine
Benzoparadiazine
Quinazine
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
229.5±0.0 °C at 760 mmHg
[ Melting Point ]:
29-32 °C(lit.)
[ Molecular Formula ]:
C8H6N2
[ Molecular Weight ]:
130.147
[ Flash Point ]:
98.3±0.0 °C
[ Exact Mass ]:
130.053101
[ PSA ]:
25.78000
[ LogP ]:
1.30
[ Vapour Pressure ]:
0.1±0.4 mmHg at 25°C
[ Index of Refraction ]:
1.653
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
SOLUBLE
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- VD1225000
- CHEMICAL NAME :
- Quinoxaline
- CAS REGISTRY NUMBER :
- 91-19-0
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 3
- MOLECULAR FORMULA :
- C8-H6-N2
- MOLECULAR WEIGHT :
- 130.16
- WISWESSER LINE NOTATION :
- T66 BN ENJ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 250 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD607-952
Safety Information
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
VD1225000
[ HS Code ]:
29339990
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933990090
[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
Antivir. Ther. (Lond.) 19(6) , 607-11, (2014)
We sought to determine the pharmacokinetic disposition of raltegravir in the blood and seminal plasma of HIV-infected men.We conducted a pharmacokinetic study using a staggered sampling approach. A to...